Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Infusion Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update” report has been added to ResearchAndMarkets.com’s offering.

This report provides comprehensive information about the Infusion Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Scope

• Extensive coverage of the Infusion Systems under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Infusion Systems and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment/industry

Reasons to Buy

The report enables you to:

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Infusion Systems under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product’s current stage of development, territory and estimated launch date

Key Topics Covered:

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 Infusion Systems Overview

3 Products under Development

3.1 Infusion Systems – Pipeline Products by Stage of Development

3.2 Infusion Systems – Pipeline Products by Segment

3.3 Infusion Systems – Pipeline Products by Territory

3.4 Infusion Systems – Pipeline Products by Regulatory Path

3.5 Infusion Systems – Pipeline Products by Estimated Approval Date

3.6 Infusion Systems – Ongoing Clinical Trials

4 Infusion Systems – Pipeline Products under Development by Companies

5 Infusion Systems Companies and Product Overview

6 Infusion Systems- Recent Developments

7 Appendix

7.1 Methodology

7.2 About the Publisher

7.3 Contact the Publisher

7.4 Disclaimer

Companies Mentioned

• Adept Medical Ltd
• Albireo Pharma Inc
• Alnylam Pharmaceuticals Inc
• AngioDynamics Inc
• Arnali, LLC
• Avoset Health Ltd
• Baxter Healthcare Corp
• Baxter International Inc
• Becton Dickinson and Co
• BioQ Pharma Inc
• Caesarea Medical Electronics Ltd
• CareFusion Corp
• ClearLine MD
• Cognos Therapeutics Inc
• Debiotech SA
• Edwards Lifesciences Corp
• Eitan Medical
• Eksigent Technologies, LLC
• Eli Lilly and Co
• EryDel SPA
• Flowonix Medical Inc
• Fluonic, Inc. (Inactive)
• Fresenius Medical Care AG & Co KGaA
• HAI Solutions Inc
• Hospira Inc
• ICU Medical Inc
• Infusense Corp
• Innofuse BV
• Innovative Health Sciences LLC
• Innovfusion Pte. Ltd.
• Intarcia Therapeutics Inc
• IRadimed Corp
• LifeMedix, LLC
• Lynntech Inc
• Massachusetts Institute of Technology
• Medical Device Creations Ltd.
• Medovate Ltd
• MonuMedical LLC
• NexGen Medical Systems Inc
• Palyon Medical Corp (Inactive)
• Pavmed Inc
• PRO-IV Medical Ltd
• Ratio Inc
• Rice University
• Sensile Medical AG
• Shift Labs Inc
• SQ Innovation AG
• Sree Chitra Tirunal Institute for Medical Sciences & Technology
• Starton Therapeutics Inc
• SteadyMed Therapeutics Inc
• StnDrd Infusion Corporation
• Supernus Pharmaceuticals Inc
• Terumo Corp
• ToucheMedical Ltd.
• TriSalus Life Sciences Inc
• Turnpoint Medical Devices Inc
• U-Needle BV
• Unilife Corporation
• United Therapeutics Corp
• University of Minnesota
• University of Southern California
• vTitan Corporation Pvt Ltd
• Zealand Pharma AS

For more information about this report visit https://www.researchandmarkets.com/r/yxlp0m

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900